• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

条件性活病毒作为一种开发安全减毒活HIV疫苗的新方法。

Conditional live virus as a novel approach towards a safe live attenuated HIV vaccine.

作者信息

Das Atze T, Zhou Xue, Vink Monique, Klaver Bep, Berkhout Ben

机构信息

Department of Human Retrovirology, Academic Medical Center, University of Amsterdam, The Netherlands.

出版信息

Expert Rev Vaccines. 2002 Oct;1(3):293-301. doi: 10.1586/14760584.1.3.293.

DOI:10.1586/14760584.1.3.293
PMID:12901570
Abstract

To control the worldwide spread of HIV, a safe and effective prophylactic vaccine is urgently needed. Studies with the simian immunodeficiency virus demonstrated that a live attenuated virus can be effective as a vaccine, but serious concerns about the safety of such a vaccine virus have arisen. We propose a conditional live virus, of which the replication can be switched on and off at will, as a novel approach for an HIV vaccine.

摘要

为了控制人类免疫缺陷病毒在全球的传播,迫切需要一种安全有效的预防性疫苗。对猿猴免疫缺陷病毒的研究表明,减毒活病毒可作为一种有效的疫苗,但人们对这种疫苗病毒的安全性产生了严重担忧。我们提出一种条件性活病毒,其复制可随意开启和关闭,作为一种新型的HIV疫苗方法。

相似文献

1
Conditional live virus as a novel approach towards a safe live attenuated HIV vaccine.条件性活病毒作为一种开发安全减毒活HIV疫苗的新方法。
Expert Rev Vaccines. 2002 Oct;1(3):293-301. doi: 10.1586/14760584.1.3.293.
2
Conditional virus replication as an approach to a safe live attenuated human immunodeficiency virus vaccine.条件性病毒复制作为一种研发安全的减毒活人类免疫缺陷病毒疫苗的方法。
J Neurovirol. 2002 Dec;8 Suppl 2:134-7. doi: 10.1080/13550280290101102.
3
In vitro evolution of a highly replicating, doxycycline-dependent HIV for applications in vaccine studies.用于疫苗研究的高复制性、强力霉素依赖性HIV的体外进化
Proc Natl Acad Sci U S A. 2001 May 22;98(11):6342-7. doi: 10.1073/pnas.111031498. Epub 2001 May 15.
4
AIDS vaccine: efficacy, safety and ethics.艾滋病疫苗:疗效、安全性与伦理道德
Vaccine. 2008 Jun 6;26(24):3072-7. doi: 10.1016/j.vaccine.2007.11.061. Epub 2007 Dec 17.
5
Improving the safety of a conditional-live human immunodeficiency virus type 1 vaccine by controlling both gene expression and cell entry.通过控制基因表达和细胞进入来提高1型人类免疫缺陷病毒条件性活疫苗的安全性。
J Virol. 2005 Mar;79(6):3855-8. doi: 10.1128/JVI.79.6.3855-3858.2005.
6
Managing HIV. Part 8: Controlling an epidemic. 8.3 Prospects for a preventive HIV vaccine.
Med J Aust. 1996 Aug 19;165(4):212-5.
7
Novel strategies toward the development of an effective vaccine to prevent human immunodeficiency virus infection or acquired immunodeficiency virus.开发有效疫苗以预防人类免疫缺陷病毒感染或获得性免疫缺陷病毒的新策略。
AIDS Clin Rev. 2000:23-61.
8
Construction of a doxycycline-dependent simian immunodeficiency virus reveals a nontranscriptional function of tat in viral replication.强力霉素依赖性猿猴免疫缺陷病毒的构建揭示了tat在病毒复制中的非转录功能。
J Virol. 2007 Oct;81(20):11159-69. doi: 10.1128/JVI.01354-07. Epub 2007 Aug 1.
9
Heterologous envelope immunogens contribute to AIDS vaccine protection in rhesus monkeys.异源包膜免疫原有助于恒河猴的艾滋病疫苗保护。
J Virol. 2004 Jul;78(14):7490-7. doi: 10.1128/JVI.78.14.7490-7497.2004.
10
Will there be a live-attenuated HIV vaccine available for human safety trials by the year 2000? Interview by Gordon Nary.到2000年时会有减毒活艾滋病毒疫苗可用于人体安全试验吗?戈登·纳里访谈录
J Int Assoc Physicians AIDS Care. 1998 Nov;4(11):22-3.

引用本文的文献

1
Synthetic biology approach for the development of conditionally replicating HIV-1 vaccine.用于开发条件性复制HIV-1疫苗的合成生物学方法。
J Chem Technol Biotechnol. 2017 Mar;92(3):455-462. doi: 10.1002/jctb.5174. Epub 2017 Feb 2.
2
Controlling Multicycle Replication of Live-Attenuated HIV-1 Using an Unnatural Genetic Switch.利用非天然基因开关控制减毒活HIV-1的多周期复制
ACS Synth Biol. 2017 Apr 21;6(4):721-731. doi: 10.1021/acssynbio.6b00373. Epub 2017 Jan 30.
3
Tet-On Systems For Doxycycline-inducible Gene Expression.
用于强力霉素诱导基因表达的Tet-On系统。
Curr Gene Ther. 2016;16(3):156-67. doi: 10.2174/1566523216666160524144041.
4
Possible applications for replicating HIV 1 vectors.复制型HIV-1载体的潜在应用。
HIV Ther. 2010 May 1;4(3):361-369. doi: 10.2217/hiv.10.20.
5
Optimization of the doxycycline-dependent simian immunodeficiency virus through in vitro evolution.通过体外进化优化强力霉素依赖性猿猴免疫缺陷病毒
Retrovirology. 2008 Jun 5;5:44. doi: 10.1186/1742-4690-5-44.
6
Construction of a doxycycline-dependent simian immunodeficiency virus reveals a nontranscriptional function of tat in viral replication.强力霉素依赖性猿猴免疫缺陷病毒的构建揭示了tat在病毒复制中的非转录功能。
J Virol. 2007 Oct;81(20):11159-69. doi: 10.1128/JVI.01354-07. Epub 2007 Aug 1.
7
Modification of the Tet-On regulatory system prevents the conditional-live HIV-1 variant from losing doxycycline-control.Tet-On调控系统的修饰可防止条件性活HIV-1变体失去强力霉素控制。
Retrovirology. 2006 Nov 9;3:82. doi: 10.1186/1742-4690-3-82.
8
Improving the safety of a conditional-live human immunodeficiency virus type 1 vaccine by controlling both gene expression and cell entry.通过控制基因表达和细胞进入来提高1型人类免疫缺陷病毒条件性活疫苗的安全性。
J Virol. 2005 Mar;79(6):3855-8. doi: 10.1128/JVI.79.6.3855-3858.2005.
9
Design and in vivo characterization of self-inactivating human and non-human lentiviral expression vectors engineered for streptogramin-adjustable transgene expression.用于链阳菌素可调节转基因表达的自失活型人源和非人源慢病毒表达载体的设计及体内特性研究
Nucleic Acids Res. 2004 Jul 16;32(12):e106. doi: 10.1093/nar/gnh104.